Provider review
NiceRx review
Taking less genuinely costs less here — at the tier level, with no milligram behind it.
There is a microdose program for each molecule, priced below the standard one by a quarter and by more than a third. What it is not is a dose: no milligram figure sits behind any price. So you know the program costs less, not what your quarter dose costs.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
NiceRx
$199/mo semaglutide, $299 tirzepatide · microdose from $149
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Prices the low dose on its own
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Take less here and you do pay less. NiceRx runs two priced tiers per molecule, with a dedicated microdose page, its own FAQ and a hub, and the microdose rate sits a quarter below the standard one on semaglutide and more than a third below on tirzepatide. That is rare enough to lead with. It goes further than the pricing, too: its own FAQ argues against pushing toward the highest dose, which cuts against its revenue, and it publishes a cancellation review from a customer who left over cost. It also prints the introductory price and the standing rate in the same breath on every card. What it costs you is precision. No milligram figure sits behind any of those four prices, so microdose is a product name here and not a specification. Both microdose rates are also starting-at, with nothing saying what pushes them higher.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a low-dose program actually priced below the standard one, not just described differently.
- You want the standing rate printed beside the first-month offer so the teaser cannot mislead you.
- You want a provider whose own copy argues against climbing to the highest dose.
- You want a non-injectable molecule option — liraglutide is sold alongside the other two.
Look elsewhere if
- You need to know how many milligrams your cheaper tier delivers. Nothing says.
- You are budgeting exactly. Both microdose rates are starting-at, and nothing explains what raises them.
- You want the starter bundle priced before you inquire. It is in the nav and nowhere on the pricing page.
- You want the dispensing pharmacy named, or your state confirmed before you order.
What it actually costs
Price as published
Compounded semaglutide $199/month standing and compounded tirzepatide $299/month standing · microdose tiers sit below them: semaglutide microdose "starting at $149 per month" and tirzepatide microdose "starting at $189 per month", each with its own page plus a hub at /glp-1-microdose/ · first month $99 semaglutide and $199 tirzepatide under a "$100 off your first month" banner, printed on the card beside the standing rate — "Compounded Semaglutide — First month: $99 $199 — $199 every month thereafter, cancel anytime" · no prepay rungs published · no week count published against "every month thereafter" · no milligram figure is published against $149, $189, $199 or $299, so the microdose tier is a product name and not a specification
- Vs median
- $30/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Prices the low dose on its own
Publishes a price for a microdose track, but no standard-dose price alongside it — so you can cost the low dose, you just cannot see what it saves you.
17 of the 373 programs we track price a small dose this way. The row records a separately named and separately priced microdose program for each molecule, published below the standard tier, each with its own page, FAQ and hub — a real step down for a reader buying less. The tier describes that step and its limit: no milligram figure is published against any price, so the cheaper tier is a product name rather than a specification, and both microdose figures are "starting at" with nothing explaining what raises them. The row also records that the cheaper pages sit outside the site's plain link graph, so a reader may never reach the tier that saves them money. ★ It also sells compounded LIRAGLUTIDE as a weekly injection with its own priced tiers, which few sellers here do at all.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Runs a genuine two-tier dose-based price structure with dedicated microdose pages, an explanatory FAQ and a hub, rather than one price for everyone — the microdose tier is 25% cheaper on semaglutide and 37% cheaper on tirzepatide
- Prints the intro price and the standing price in the same breath on every product card — "First month: $99 $199 — $199 every month thereafter" — which is the single most useful pricing pattern there is
- Explicitly rejects dose-maximizing in its own FAQ copy, which cuts against its own revenue: "the emphasis is on identifying your optimal effective dose, rather than pushing toward the highest dose possible"
- Publishes a bad review — a cancellation for cost reasons — alongside the good ones
- Carries an unusually direct compounding disclaimer: compounded microdose medications "are only indicated when a prescribing practitioner determines they offer a significant difference from the FDA-approved product"
Pharmacy, labs and oversight
NiceRx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What NiceRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
NiceRx sells compounded semaglutide, compounded tirzepatide and liraglutide as weekly injections, with two priced tiers per molecule: a standard program and a separately named microdose program with its own page, FAQ and hub. Prices are published on a public pricing page, with the introductory first month and the standing rate printed side by side on every card. Its microdose FAQ frames the goal as finding an optimal effective dose rather than the highest one. No compounding pharmacy is named on the pages read, and no milligram figure appears against any price.
The honest cons
NO MILLIGRAM FIGURE IS PUBLISHED AGAINST ANY PRICE. The microdose tier is genuinely cheaper, but "microdose" here names a product rather than an amount, so what a quarter dose costs still cannot be computed
- BOTH MICRODOSE PRICES ARE "STARTING AT" — $149 and $189 — and nothing explains what inside the microdose program costs more
- The cheaper microdose pages are reachable from the scripted menu and the sitemap but not from the site's plain links, so a reader can easily never find the tier that would save them money
- A third weight-loss entry, "Starter bundle", appears in the nav with no price anywhere on the pricing page
- No week count is published against "every month thereafter", so an annual cost cannot be computed
- No compounding pharmacy is named on the pages read
- States served are not published
- The LegitScript seal carries no numeric ID on the page, so the certification cannot be resolved from it
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
NiceRx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#93 of 373
Ordered with the companies that pay us first, and NiceRx is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Aurelius Health Group
$89 first month, then $199/mo
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Prices the low dose on its own
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Aurelius Health Group review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.